{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:52:27Z","timestamp":1794887547304,"version":"4.9.1"},"reference-count":18,"publisher":"SAGE Publications","issue":"8","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Phlebology"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the effectiveness and safety of High-Intensity Focused Ultrasound (HIFU) treatment in Chronic Venous Insufficiency (CVI) using a hemodynamic approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This real-world, observational, and retrospective study analyzed 80 patients with CVI from stage C2 to C5 (Clinical, Etiological, Anatomical, and Pathophysiological (CEAP) classification). A single vascular surgeon included and treated all patients consecutively between September 2022 and July 2023. Outcomes were assessed by Doppler ultrasound at 1-month and 1-year. The primary outcome was technical success (complete\/partial occlusion by reducing reflux involving reduction in vein diameter &gt;50%); the secondary outcomes included clinical improvement, measured by the Aberdeen varicose vein questionnaire (AVVQ) with visual analogue scale (VAS) and adverse effects. Descriptive statistics include 95% confidence intervals (CI). Subgroups were compared using Chi-squared\/Fisher\u2019s or Student\u2019s t-test\/Wilcoxon tests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Treated veins included great saphenous veins (GSV), small saphenous veins (SSV), anterior accessory saphenous veins (AASV), leg perforating veins (LPV), thigh perforating veins (TPV), perineal veins and GSV neocrosses. At 1-month follow-up, technical success reached 80.6% (95% CI 74.8\u201385.5%) of cases, with optimal outcomes for LPV (94.4%) and GSV (87.5%). Clinical improvement occurred in 78.8% of patients (68.81\u201386.54%). At baseline, patients were stratified into subgroups according to their CEAP stage. No significant difference in improvement rates was found across these subgroups (C2S: 78.7%, C3: 83.3%, C4: 75%, C5: 85.7%,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.83). However, adverse events occurred in 21.8% of cases, the most frequent being neuropathic pain (5%) and skin burns (5%), all quickly resolved.\n                    <\/jats:p>\n                    <jats:p>One-year per-protocol analysis showed maintained technical success at 79% (73.8\u201383.9%) and clinical improvement at 95.2% (84.2\u201399.4%) despite the attrition of 36% of participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>HIFU treatment demonstrates lasting effectiveness for CVI, particularly on LPV and GSV, with an acceptable safety profile. Limitations include a steep learning curve and anatomical constraints. Further studies are necessary for confirmation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/02683555261418961","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T14:48:47Z","timestamp":1769006927000},"page":"724-734","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessing the effectiveness and safety of high-intensity focused ultrasound in treating venous insufficiency using a hemodynamic approach"],"prefix":"10.1177","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7124-8536","authenticated-orcid":false,"given":"Sara","family":"Chabouni","sequence":"first","affiliation":[{"name":"Argenteuil Hospital Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahine","family":"Kashi","sequence":"additional","affiliation":[{"name":"Argenteuil Hospital Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Chauvel","sequence":"additional","affiliation":[{"name":"Argenteuil Hospital Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassel","family":"Dakhil","sequence":"additional","affiliation":[{"name":"Argenteuil Hospital Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rym","family":"Zaimi","sequence":"additional","affiliation":[{"name":"Argenteuil Hospital Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Pons","sequence":"additional","affiliation":[{"name":"Argenteuil Hospital Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Bagan","sequence":"additional","affiliation":[{"name":"Argenteuil Hospital Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2018.230"},{"key":"e_1_3_7_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000004631"},{"key":"e_1_3_7_4_2","unstructured":"Editor\u2019s Choice \u2013 European Society for Vascular Surgery (ESVS) 2022 Clinical practice guidelines on the management of chronic venous disease of the lower limbs - European Journal of Vascular and Endovascular Surgery n.d. https:\/\/www.ejves.com\/article\/S1078-5884(21)00979-5\/fulltext#secsectitle0020 (accessed 19 December 2023)."},{"key":"e_1_3_7_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.4701"},{"key":"e_1_3_7_6_2","first-page":"1","article-title":"Therapeutic innovation in chronic venous disease: echotherapy or treatment with high intensity focused ultrasound (HIFU)","volume":"75","author":"De Deken M","year":"2022","unstructured":"De Deken M, Stalnikiewicz G. Therapeutic innovation in chronic venous disease: echotherapy or treatment with high intensity focused ultrasound (HIFU). Phl\u00e9bologie 2022; 75: 1\u201312.","journal-title":"Phl\u00e9bologie"},{"key":"e_1_3_7_7_2","unstructured":"Dominique T. Occlusion de veine saph\u00e8ne par laser par voie veineuse transcutan\u00e9e : actualisation de l'\u00e9valuation conduite en 2008. Haute Autorit\u00e9 de Sant\u00e9 (HAS). 2016. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2016-12\/rapport_laser_endoveineux_vd.pdf (accessed March 27 2024)."},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.7555"},{"key":"e_1_3_7_9_2","volume-title":"Actualit\u00e9 - Traitement des varices: rappel des conduites \u00e0 tenir pour r\u00e9duire les risques cardiovasculaires li\u00e9s \u00e0 l\u2019utilisation des scl\u00e9rosants veineux","unstructured":"Actualit\u00e9 - Traitement des varices: rappel des conduites \u00e0 tenir pour r\u00e9duire les risques cardiovasculaires li\u00e9s \u00e0 l\u2019utilisation des scl\u00e9rosants veineux. ANSM. n.d. https:\/\/ansm.sante.fr\/actualites\/traitement-des-varices-rappel-des-conduites-a-tenir-pour-reduire-les-risques-cardiovasculaires-lies-a-lutilisation-des-sclerosants-veineux (accessed March 2, 2024)."},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2020.1834626"},{"key":"e_1_3_7_11_2","doi-asserted-by":"publisher","DOI":"10.1098\/rsif.2014.0029"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2008.06.030"},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.1067\/mva.2003.142"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.1024\/0301-1526\/a000610"},{"key":"e_1_3_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvsv.2025.102233"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.1177\/02683555241243161"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvsvf.2020.11.005"},{"key":"e_1_3_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.suc.2017.11.014"},{"key":"e_1_3_7_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2019.1699518"}],"container-title":["Phlebology: The Journal of Venous Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02683555261418961","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02683555261418961","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02683555261418961","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T23:21:58Z","timestamp":1787095318000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02683555261418961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1177\/02683555261418961"],"URL":"https:\/\/doi.org\/10.1177\/02683555261418961","relation":{},"ISSN":["0268-3555","1758-1125"],"issn-type":[{"value":"0268-3555","type":"print"},{"value":"1758-1125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]}}}